{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:40:02Z","timestamp":1793504402982,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL164415-01"],"award-info":[{"award-number":["1R01HL164415-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX002137"],"award-info":[{"award-number":["I01 BX002137"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0424"],"award-info":[{"award-number":["W81XWH-21-1-0424"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152455","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:06:55Z","timestamp":1754449615000},"page":"152455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel therapeutic cav1.3-C-terminus normalizes L-type calcium current and ejection fraction in ischemia-induced murine heart failure"],"prefix":"10.1016","volume":"779","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8985-2290","authenticated-orcid":false,"given":"Michael","family":"Cupelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi Krishna","family":"Murthy Ginjupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia Sarah","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boutjdir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bbrc.2025.152455_bib1","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the heart failure society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152455_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000132","article-title":"2024 update to the 2020 ACC\/AHA clinical performance and quality measures for adults with heart failure: a report of the American heart association\/american college of cardiology joint committee on performance measures","volume":"17","author":"Kittleson","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.bbrc.2025.152455_bib3","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2021.18","article-title":"The gap to fill: rationale for rapid initiation and optimal titration of comprehensive disease-modifying medical therapy for heart failure with reduced ejection fraction","volume":"7","author":"Brownell","year":"2021","journal-title":"Card. Fail. Rev."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152455_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ahj.2011.01.027","article-title":"Potential impact of optimal implementation of evidence-based heart failure therapies on mortality","volume":"161","author":"Fonarow","year":"2011","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152455_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.bbrc.2025.152455_bib6","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American heart association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.bbrc.2025.152455_bib7","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/CIRCULATIONAHA.117.031622","article-title":"Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction","volume":"137","author":"Pandey","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152455_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184134","article-title":"Mechanisms of postischemic cardiac death and protection following myocardial injury","volume":"135","author":"Mastoor","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152455_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093167","article-title":"Ischemic heart disease and heart failure: role of coronary ion channels","volume":"21","author":"Severino","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152455_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.05.004","article-title":"Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts","volume":"158","author":"Ritterhoff","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102968","article-title":"Mitochondrial dysfunction and calcium homeostasis in heart failure: exploring the interplay between oxidative stress and cardiac remodeling for future therapeutic innovations","volume":"50","author":"Johnson","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.bbrc.2025.152455_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1144069","article-title":"Pathophysiology of Ca(v)1.3 L-type calcium channels in the heart","volume":"14","author":"Zaveri","year":"2023","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152455_bib13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.hrthm.2020.02.025","article-title":"Novel re-expression of L-type calcium channel Ca(v)1.3 in left ventricles of failing human heart","volume":"17","author":"Srivastava","year":"2020","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.bbrc.2025.152455_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11897-012-0116-6","article-title":"Assessment of ventricular remodeling in heart failure clinical trials","volume":"9","author":"Kirkpatrick","year":"2012","journal-title":"Curr. Heart Fail. Rep."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152455_bib15","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1074\/jbc.M114.586883","article-title":"Regulation of gene transcription by voltage-gated L-type calcium channel, Cav1.3","volume":"290","author":"Lu","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152455_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0008-6363(98)00110-2","article-title":"Animal models of human cardiovascular disease, heart failure and hypertrophy","volume":"39","author":"Hasenfuss","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152455_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0008-6363(99)00017-6","article-title":"Electrophysiological remodeling in hypertrophy and heart failure","volume":"42","author":"Tomaselli","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s003950170054","article-title":"Electrophysiological characterization of murine myocardial ischemia and infarction","volume":"96","author":"Gehrmann","year":"2001","journal-title":"Basic Res. Cardiol."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152455_bib19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib20","first-page":"215","article-title":"Viral vector biosafety in laboratory animal research","volume":"67","author":"Collins","year":"2017","journal-title":"Comp. Med."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152455_bib21","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCRESAHA.111.249433","article-title":"Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts","volume":"109","author":"Lee","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152455_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117562","article-title":"Calcium handling abnormalities increase arrhythmia susceptibility in DMSXL myotonic dystrophy type 1 mice","volume":"180","author":"Cupelli","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152455_bib23","doi-asserted-by":"crossref","first-page":"H2017","DOI":"10.1152\/ajpheart.00537.2008","article-title":"Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1D L-type Ca2+ channel KO mouse","volume":"295","author":"Mancarella","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152455_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0195-668X(02)00829-1","article-title":"Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy","volume":"24","author":"Lips","year":"2003","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1742-7843.2010.00564.x","article-title":"Metoprolol treatment lowers thrombospondin-4 expression in rats with myocardial infarction and left ventricular hypertrophy","volume":"107","author":"Mustonen","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152455_bib26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/gt.2011.147","article-title":"Low-density lipoprotein receptor gene transfer in hypercholesterolemic mice improves cardiac function after myocardial infarction","volume":"19","author":"Van Craeyveld","year":"2012","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152455_bib27","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1073\/pnas.91.7.2694","article-title":"Molecular and physiological alterations in murine ventricular dysfunction","volume":"91","author":"Rockman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.carpath.2011.05.002","article-title":"Variable phenotype in murine transverse aortic constriction","volume":"21","author":"Mohammed","year":"2012","journal-title":"Cardiovasc. Pathol."},{"issue":"42","key":"10.1016\/j.bbrc.2025.152455_bib29","doi-asserted-by":"crossref","first-page":"38727","DOI":"10.1074\/jbc.M103724200","article-title":"Functional properties of Cav1.3 (alpha1D) L-type Ca2+ channel splice variants expressed by rat brain and neuroendocrine GH3 cells","volume":"276","author":"Safa","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152455_bib30","first-page":"1211","article-title":"Functional expression and characterization of a voltage-gated CaV1.3 (alpha1D) calcium channel subunit from an insulin-secreting cell line","volume":"15","author":"Scholze","year":"2001","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152455_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1203\/PDR.0b013e318217a0df","article-title":"Perinatal and postnatal expression of Cav1.3 alpha1D Ca(2)(+) channel in the rat heart","volume":"69","author":"Qu","year":"2011","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152455_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050785","article-title":"Various AAV serotypes and their applications in gene therapy: an overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bbrc.2025.152455_bib33","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMoa2412392","article-title":"Phase 1 study of AAV9.LAMP2B gene therapy in danon disease","volume":"392","author":"Greenberg","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152455_bib34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","article-title":"The AAV vector toolkit: poised at the clinical crossroads","volume":"20","author":"Asokan","year":"2012","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152455_bib35","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152455_bib36","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","article-title":"Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo","volume":"99","author":"Pacak","year":"2006","journal-title":"Circ. Res."},{"issue":"92","key":"10.1016\/j.bbrc.2025.152455_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002097","article-title":"Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model","volume":"3","author":"Pleger","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152455_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1538-7836.2006.02220.x","article-title":"Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy","volume":"5","author":"Vandendriessche","year":"2007","journal-title":"J. Thromb. Haemostasis"},{"issue":"6868","key":"10.1016\/j.bbrc.2025.152455_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152455_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152455_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.113.301781","article-title":"Regulation of cardiac L-type Ca(2)(+) channel CaV1.2 via the beta-adrenergic-cAMP-protein kinase A pathway: old dogmas, advances, and new uncertainties","volume":"113","author":"Weiss","year":"2013","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152455_bib42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.hrthm.2011.11.055","article-title":"BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes","volume":"9","author":"Hong","year":"2012","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1172\/JCI115969","article-title":"Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure","volume":"90","author":"Takahashi","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152455_bib44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.98.10.969","article-title":"Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle","volume":"98","author":"Schroder","year":"1998","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152455_bib45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jchf.2018.05.004","article-title":"Heart failure with improved ejection fraction: is it possible to escape one's past?","volume":"6","author":"Gulati","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152455_bib46","article-title":"Management of arrhythmias in heart failure","volume":"4","author":"Masarone","year":"2017","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152455_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.9003","article-title":"LV-predominant arrhythmogenic cardiomyopathy related to pathogenic DSP-Variant","volume":"12","author":"Ahmad","year":"2024","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative first-line effectiveness and safety of ACE (Angiotensin-Converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2025.152455_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2022.10.026","article-title":"Network meta-analysis comparing angiotensin receptor-neprilysin inhibitors, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors in heart failure with reduced ejection fraction","volume":"187","author":"Park","year":"2023","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/CIRCHEARTFAILURE.108.806240","article-title":"Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure","volume":"2","author":"Maurer","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.bbrc.2025.152455_bib51","first-page":"6","article-title":"Mineralocorticoid receptor antagonist in heart failure: past, present and future perspectives","volume":"3","author":"Vizzardi","year":"2014","journal-title":"Int J Cardiol Heart Vessel"},{"issue":"17","key":"10.1016\/j.bbrc.2025.152455_bib52","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152455_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.36628\/ijhf.2022.0030","article-title":"SGLT-2 inhibitors in heart failure: a review of current evidence","volume":"5","author":"Talha","year":"2023","journal-title":"Int J Heart Fail"},{"key":"10.1016\/j.bbrc.2025.152455_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yjmcc.2014.11.017","article-title":"Perturbed atrial calcium handling in an ovine model of heart failure: potential roles for reductions in the L-type calcium current","volume":"79","author":"Clarke","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152455_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbrc.2011.05.113","article-title":"Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic reticulum Ca2+ uptake in human atrial fibrillation","volume":"410","author":"Shanmugam","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152455_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCEP.107.754788","article-title":"Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure","volume":"1","author":"Yeh","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152455_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molimm.2014.06.036","article-title":"A vital role for complement in heart disease","volume":"61","author":"Lappegard","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrc.2025.152455_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/srep42532","article-title":"The alternative complement pathway is dysregulated in patients with chronic heart failure","volume":"7","author":"Shahini","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152455_bib59","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.40193","article-title":"Brief report: Association of elevated adipsin levels with pulmonary arterial hypertension in systemic sclerosis","volume":"69","author":"Korman","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152455_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/cvr\/cvu201","article-title":"Balanced changes in Ca buffering by SERCA and troponin contribute to Ca handling during beta-adrenergic stimulation in cardiac myocytes","volume":"104","author":"Briston","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152455_bib61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCRESAHA.119.315891","article-title":"The control of diastolic calcium in the heart: basic mechanisms and functional implications","volume":"126","author":"Eisner","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152455_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25011702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25011702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:29:23Z","timestamp":1779769763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25011702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":62,"alternative-id":["S0006291X25011702"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152455","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel therapeutic cav1.3-C-terminus normalizes L-type calcium current and ejection fraction in ischemia-induced murine heart failure","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152455"}}